Status:
UNKNOWN
Flaxseed Supplementation in Prediabetic Adults (LINAPRED)
Lead Sponsor:
Centro Universitario de Ciencias de la Salud, Mexico
Conditions:
Prediabetic State
Eligibility:
All Genders
30-59 years
Phase:
NA
Brief Summary
Prediabetes is the term used to describe the condition where blood glucose level is higher than normal but lower than the diagnosis criteria of type 2 diabetes mellitus (T2DM). This condition confers ...
Detailed Description
Prediabetes is a condition that increases the risk of T2DM and other diseases, its prevalence increases year after year despite being a reversible condition through lifestyle changes, diet, and medica...
Eligibility Criteria
Inclusion
- Patients who agree to participate in the study once they have read and signed the informed consent
- Men and women
- Fasting glucose levels between 100 and 125 mg/dl
- Age 30-59 years
- Stable weight in the last 3 months (no more than 5% weight change)
Exclusion
- Fasting glucose \<100 and \>125 mg/dl
- Anemia
- Consumption of drugs that may modify glucose levels
- Consumption of flaxseed, chia, or omega-3, three months before the study
- Alternative diets (vegetarian, vegan, ketogenic, etc.)
- Pregnancy and breastfeeding
- Allergy or intolerance to flaxseed
Key Trial Info
Start Date :
November 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 20 2024
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT05245825
Start Date
November 20 2021
End Date
February 20 2024
Last Update
February 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidad de Guadalajara (CUCS)
Guadalajara, Jalisco, Mexico, 44340